Please assess the completion status of the following clinical trial:

Trial Title: Effect Of Intravenous Hyoscine -N-Butyl Bromide In Management Of Prolonged Labor In Nulliparous

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* • Nulliparous women.~  * cervical dilatation in the active phase of less than 1.2 cm/h for nulliparous women~ * Gestational age ≥ 37 weeks.~ * Singleton pregnancy.~ * Vertex presentation.~ * Cervical dilatation ≥ 4cm.~ * No evidence of maternal or fetal distress.~ * Average size baby.~Exclusion Criteria:~* History of cervical surgery.~* Mal-presentation and mal-positions.~* Hypersensitivity to Hyoscine.~* Contraindication for vaginal delivery.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Hyoscine group (Type: ACTIVE_COMPARATOR): 7. Group A will receive injection Hyoscine butyl bromide 40 mg single intravenous dose
- Control group (Type: PLACEBO_COMPARATOR): Group B, will receive 2 ml of normal saline single intravenous dose

Based on this trial design, predict the completion outcome and termination type (if applicable).